Nephrology

Very low incidence of end stage renal disease (ESRD) was found in patients with childhood-onset diabetes type 1 in Norway.

Although the risk of end-stage renal disease remains high for individuals with type 1 diabetes, lifetime likelihood of ESRD has substantially decreased over the last 50 years.

SGLT-2 inhibitors were associated with more acute renal failure reports than other diabetes medications.

Canagliflozin may reduce the risk of major cardiovascular complication, but amputation risk is increased.

In this week's Homerun Slides, testing albuminuria and potassium levels.

In part 5 of this Exclusive Interview, Dr. Mark Molitch explains the changes in diabetes care that have resulted in the dramatic decrease in renal failure in diabetes patients in a conversation with Diabetes in Control Publisher Steve Freed during the ADA meeting in San Diego, California.

In this week's Homerun Slides, schema of the action of the Glycocalyx.

CKD risk not necessarily tied to albuminuria in patients with type 1 diabetes.

In this week's Homerun Slides, Dr. Claude Lardinois focuses on the importance of albuminuria as it relates to chronic kidney disease in people with type 2 diabetes.

New data from the EMPA-REG-OUTCOME study provide more evidence of the renoprotective effects of empagliflozin in patients with type 2 and cardiovascular disease.